Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Alamar Biosciences in the transaction. Alamar Biosciences announced it raised $128 million in Series C financing round. The financing round…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
